We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+12.39%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$19.4B
AUM Growth
+$2.11B
(+12%)
Cap. Flow
+$90.4M
Cap. Flow
% of AUM
0.47%
Top 10 Holdings %
Top 10 Hldgs %
53.93%
Holding
1,534
New
81
Increased
246
Reduced
456
Closed
138
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$105M |
| 2 |
Match Group
MTCH
|
+$77.8M |
| 3 |
NextEra Energy
NEE
|
+$64.3M |
| 4 |
Keysight
KEYS
|
+$62.4M |
| 5 |
AutoZone
AZO
|
+$56.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$82.5M |
| 2 |
Microsoft
MSFT
|
+$42.5M |
| 3 |
Apple
AAPL
|
+$38.2M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$27M |
| 5 |
Johnson & Johnson
JNJ
|
+$22.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 38.9% |
| 2 | Technology | 17.9% |
| 3 | Healthcare | 11.08% |
| 4 | Communication Services | 8.12% |
| 5 | Consumer Discretionary | 7.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
CytomX Therapeutics
CTMX
$705M
| $2.3M | 0.01% |
345,451
-307,105
| -47% | -$2.28M |
|
277
Chemung Financial Corp
CHMG
$390M
| $2.28M | 0.01% |
78,956
-1,700
| -2% | -$48.5K |
|
278
Teva Pharmaceuticals
TEVA
$35.9B
| $2.26M | 0.01% |
251,245
+1,468
| +0.6% | +$15.5K |
|
279
Allstate
ALL
$66.9B
| $2.26M | 0.01% |
24,031
-133
| -0.6% | -$12.4K |
|
280
Vanguard Small-Cap ETF
VB
$79.5B
| $2.25M | 0.01% |
14,634
+1,480
| +11% | +$227K |
|
281
Lockheed Martin
LMT
$134B
| $2.24M | 0.01% |
5,850
| – | – |
|
|
UBA
282
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $2.23M | 0.01% |
243,006
+153,630
| +172% | +$1.52M |
|
|
BRKL
283
DELISTED
Brookline Bancorp
BRKL
| $2.21M | 0.01% |
255,254
-1,000
| -0.4% | -$9.51K |
|
284
Gen Digital
GEN
$15.6B
| $2.2M | 0.01% |
105,527
-300
| -0.3% | -$6.49K |
|
285
American International
AIG
$41.9B
| $2.19M | 0.01% |
79,701
-11,623
| -13% | -$346K |
|
286
Vanguard US Multifactor ETF
VFMF
$717M
| $2.18M | 0.01% |
30,639
| – | – |
|
287
Vanguard Total Stock Market ETF
VTI
$654B
| $2.17M | 0.01% |
12,775
+75
| +0.6% | +$12.6K |
|
288
iShares Core S&P Small-Cap ETF
IJR
$109B
| $2.16M | 0.01% |
30,753
+1,529
| +5% | +$110K |
|
289
Starbucks
SBUX
$118B
| $2.15M | 0.01% |
25,000
+1,720
| +7% | +$137K |
|
290
Onto Innovation
ONTO
$13.6B
| $2.14M | 0.01% |
71,900
| – | – |
|
291
GE Aerospace
GE
$367B
| $2.13M | 0.01% |
68,607
-13,130
| -16% | -$427K |
|
292
Amphenol
APH
$188B
| $2.13M | 0.01% |
78,580
| – | – |
|
|
BRT
293
BRT Apartments
BRT
$282M
| $2.1M | 0.01% |
178,757
-12,370
| -6% | -$144K |
|
|
BSTC
294
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $2.04M | 0.01% |
38,575
| – | – |
|
|
RPT
295
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $2.03M | 0.01% |
374,075
-30,600
| -8% | -$188K |
|
296
Stanley Black & Decker
SWK
$14.2B
| $2.03M | 0.01% |
12,514
-300
| -2% | -$46.7K |
|
|
Y
297
DELISTED
Alleghany Corp
Y
| $2M | 0.01% |
3,843
-250
| -6% | -$131K |
|
|
BLU
298
DELISTED
BELLUS Health Inc.
BLU
| $1.99M | 0.01% |
876,732
| – | – |
|
299
L3Harris
LHX
$55.9B
| $1.99M | 0.01% |
11,714
+1,235
| +12% | +$217K |
|
300
Pinnacle West Capital
PNW
$12.9B
| $1.97M | 0.01% |
26,459
| – | – |
|
Similar funds
SAM
First Manhattan's Q3 2020 Portfolio in Review
As of Q3 2020, First Manhattan held 1,534 positions worth $19.4B, up 12% from $17.3B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
First Manhattan's Q3 2020 filing shows 81 new, 246 increased, 456 reduced and 138 closed positions. Its largest new stake was Constellation Pharmaceuticals, Inc.: 250,400 shares worth $5.07M. The largest sale was People Inc, an estimated $82.5M.
By sector, the portfolio is most concentrated in Financials at 39% of assets, up from 38% a quarter earlier, followed by Technology and Healthcare.
- First Manhattan's largest Q3 2020 buy was Constellation Pharmaceuticals, Inc.: 250,400 shares worth $5.07M.
- First Manhattan added most to UnitedHealth in Q3 2020, an estimated $105M increase.
- First Manhattan's biggest Q3 2020 reduction was People Inc, cutting an estimated $82.5M.
- First Manhattan fully exited Aimmune Therapeutics in Q3 2020, selling an estimated $17.1M.
- First Manhattan's ten largest holdings make up 54% of its $19.4B portfolio in Q3 2020.
- First Manhattan opened 81 new positions and closed 138 in Q3 2020.
- First Manhattan's portfolio value rose 12% quarter-over-quarter to $19.4B.
Based on First Manhattan's 13F filing for Q3 2020, filed 12 Nov 2020.